3D Systems

3D Systems is a global leader in additive manufacturing and digital fabrication. In healthcare/life sciences, it provides advanced bioprinting platforms—including printers, biomaterials/bioinks, software, and services—enabling pharmaceutical companies and researchers to create vascularized human tissue models ("organs-on-chips") that accelerate drug discovery/development. Its wholly owned biotech subsidiary Systemic Bio focuses on commercializing these organ models using the proprietary h-VIOS™ hydrogel-based chip system. The company also supports regenerative medicine with programs like RTP for patient-specific soft tissue implants. While not a therapeutic developer itself, its technologies underpin preclinical research across pharma/biotech sectors aiming to reduce animal testing and improve translational relevance of early-stage studies.